| Unique ID issued by UMIN | UMIN000056452 |
|---|---|
| Receipt number | R000064510 |
| Scientific Title | K-PReP (Kawasaki-city Cardiac Prevention and Rehabilitation Consortium Project) registry clinical trial |
| Date of disclosure of the study information | 2024/12/16 |
| Last modified on | 2025/12/14 11:35:37 |
K-PReP (Kawasaki-city Cardiac Prevention and Rehabilitation Consortium Project) registry clinical trial
K-PReP registry clinical trial
K-PReP (Kawasaki-city Cardiac Prevention and Rehabilitation Consortium Project) registry clinical trial
K-PReP registry clinical trial
| Japan |
Cardiac disease
| Cardiology |
Others
NO
We will verify the safety, feasibility, and effectiveness of using a smartphone app for outpatient asynchronous cardiac rehabilitation in the late recovery/maintenance phase, and build evidence. In addition, we will construct a dataset that can be utilized in various situations in the future.
Efficacy
Change in 6-minute walking distance
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
| Device,equipment |
Use of smartphone apps
| 20 | years-old | <= |
| Not applicable |
Male and Female
Cardiac rehabilitation patients 20 years of age or older who have been discharged home after cardiac catheterization or surgery for cardiac disease and who retain a smartphone that enables them to perform daily activities of walking outdoors without a cane.
1) Patients who are unable to give their written consent
2) Patients who are unable to fill out the questionnaire on their own
3) Patients who cannot walk to the hospital with a cane or on their own
4) Patients with the following cardiac diseases (acute myocardial infarction [within 2 days of onset], pre-treatment unstable angina, uncontrolled arrhythmia, symptomatic severe aortic stenosis, uncontrolled symptomatic heart failure, acute pulmonary thromboembolism, acute myocarditis/pericarditis, acute aortic dissection, and after pacemaker/implantable cardioverter defibrillator implantation) (after pacemaker/implantable cardioverter-defibrillator implantation)
5) Pregnant and lactating patients
6) Patients with other serious diseases (e.g., cancer, collagen disease, etc.) for which the investigator determines that the patient is not suitable for this study.
150
| 1st name | Toshiki |
| Middle name | |
| Last name | Kaihara |
St. Marianna University School of Medicine
Department of Cardiology
2250003
2-16-1 Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan
0449778111
tk-presen2@marianna-u.ac.jp
| 1st name | Toshiki |
| Middle name | |
| Last name | Kaihara |
St. Marianna University School of Medicine
Dapartment of Cardiology
2168511
2-16-1 Sugao, Miyamae-ku, Kawasaki, 216-8511, Japan
044-977-8111
tk-presen2@marianna-u.ac.jp
St. Marianna University School of Medicine
N/A
Other
St. Marianna University School of Medicine
2-16-1, Sugao, Miyamae-ku, Kawasaki, Kanagawa
0449778111
k-sienbu.mail@marianna-u.ac.jp
NO
| 2024 | Year | 12 | Month | 16 | Day |
Unpublished
| Delay expected |
Patient enrollment is delayed.
Enrolling by invitation
| 2024 | Year | 12 | Month | 27 | Day |
| 2024 | Year | 12 | Month | 11 | Day |
| 2024 | Year | 12 | Month | 16 | Day |
| 2026 | Year | 03 | Month | 31 | Day |
| 2024 | Year | 12 | Month | 13 | Day |
| 2025 | Year | 12 | Month | 14 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064510